Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Carney to meet UK Prime Minister Andy Burnham for first time

September 12, 2026

Blue Bombers pick ‘Riders apart in Banjo Bowl

September 12, 2026

Canada to co-host conference on returning Ukrainian kids, detainees

September 12, 2026

Ontario man faces 8 charges for voyeurism, sexual assault at tailor shop

September 12, 2026

Jays’ Cease replaces painting in skipper’s office

September 12, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Press Release

Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal

By News RoomJanuary 13, 20262 Mins Read
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Share
Facebook Twitter LinkedIn Pinterest Email
  • Renewal marks over a decade of Halal compliance, securing critical supply chains for biopharmaceutical growth markets through 2026 and beyond.

MINNETONKA, Minn., Jan. 13, 2026 (GLOBE NEWSWIRE) — Nu-Tek BioSciences, the industry leader in 100% animal-origin-free (AOF) peptones and yeast extracts, announced today that it has successfully renewed its Halal certification from The Islamic Food and Nutrition Council of America (IFANCA). This certification reinforces Nu-Tek’s decade-long standing as a trusted partner to the global pharmaceutical, biotechnology, and industrial fermentation sectors.

Halal certification is essential for materials distributed throughout the Middle East and Southeast Asia—markets currently facing heightened regulatory standards slated for 2026. By maintaining these rigorous standards, Nu-Tek provides its global partners with an ethically sourced, high-performance supply chain that is technically and culturally compliant with evolving international requirements.

“We strive to be the partner that understands both the complex science of raw materials and the specific nuances of our customers’ regional market expectations,” said Tom Yezzi, CEO of Nu-Tek BioSciences. “Our sustained Halal designation enhances our ability to meet the expanding demand for compliant, animal-free ingredients in the world’s fastest-growing biopharmaceutical hubs.”

As the industry shifts toward a more holistic view of raw material qualification, incorporating religious and ethical considerations alongside technical specifications, Nu-Tek remains at the forefront. This designation, paired with the company’s Kosher/Organic certifications, and proprietary Variability Reduction Program (VRP), underscores Nu-Tek’s commitment to providing the most predictable and accessible raw material solutions in the biopharmaceutical industry.

About Nu-Tek BioSciences

Nu-Tek BioSciences is the market leader in the development and manufacturing of high-quality, 100% animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek’s innovative solutions are essential for cell culture and microbial fermentation, supporting the production of vaccines, therapeutics, and other vital biologics. More product information is available at www.nu-tekbiosciences.com.

Media Contact:

Courtney Jones
Director of Commercial Development
[email protected]
+1(952) 936.3614
www.nu-tekbiosciences.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e540576-ddcd-4440-9264-e238409147b5

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3db37752-2106-41c7-ad4a-dc17dc2e46e6

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

REGN 2-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Building Global Trust in the AI Search Era: DigiMentumPR Explores the Future of PR for Technology Brands

LetPot Marks 7th Anniversary With Successful Smart Gardening Showcase at IFA Berlin 2026

RaserTech.com: From Geothermal Energy to AI GPU Infrastructure

Pardu Productions Publishes Exclusive Feature on Marc Mysterio's Proposed “Name vs. Name” Match

[Crypto Market News] Apeing Announces Stage 3 Presale at $0.0004 as More Than 400 Million $APEING Tokens Are Sold

Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise

Disective Recovery Limited Announces Expanded Financial Fraud Case Assessment Service for Investment Scam Victims

Neuro Launches Energy & Focus Sour Mints in Three Bold Flavors

Editors Picks

Blue Bombers pick ‘Riders apart in Banjo Bowl

September 12, 2026

Canada to co-host conference on returning Ukrainian kids, detainees

September 12, 2026

Ontario man faces 8 charges for voyeurism, sexual assault at tailor shop

September 12, 2026

Jays’ Cease replaces painting in skipper’s office

September 12, 2026

Latest News

StarCraft returns in 2030 as an open-world shooter

September 12, 2026

Trump says Canada ‘wants to make a deal very badly’

September 12, 2026

REGN 2-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

September 12, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version